Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas

Keyphrases

• Protein Profiling 100%
• Meningioma 100%
• Tumor Marker 100%
• Minichromosome Maintenance Proteins 100%
• Minichromosome Maintenance 33%
• Meningioma Cells 33%
• 4-fold 33%
• NanoLC 33%
• Brain Meningioma 33%
• Tissue Sampling 16%
• Spinal Cord 16%
• Tumor 16%
• Quantitative PCR 16%
• Biological Function 16%
• Protein Biomarkers 16%
• Validation Studies 16%
• MCM2 16%
• DNA Replication 16%
• Recombination 16%
• Novel Protein 16%
• Expression Level 16%
• Tumorigenesis 16%
• MCM5 16%
• MS-MS 16%
• Central Nervous System Tumors 16%
• Protein Identification 16%
• Neurofibromatosis Type 2 16%
• Diagnostic Marker 16%
• Autopsy 16%
• Gunshot 16%
• MCM6 16%
• Cell Apoptosis 16%
• Tandem Mass Spectrometry 16%
• Mass Spectral 16%
• MCM3 16%
• Tumor Samples 16%
• Isolated Protein 16%
• Protein Profile 16%
• Spectral Counting 16%
• Protein Quantification 16%
• Differential Analysis 16%
• Up-regulated Proteins 16%
• MCM4 16%
• MCM7 16%
• WHO Grade I 16%
• In-depth Proteomics 16%
• Neurofibromatosis Type 1 (NF-1) 16%
• Family Protein 16%
• WHO Grade II 16%
• WHO Grade III 16%
• Meningioma Subtype 16%

Biochemistry, Genetics and Molecular Biology

• Minichromosome Maintenance 100%
• Tumor Marker 100%
• Quantitative Reverse Transcription Polymerase Chain Reaction 33%
• MCM2 33%
• Tandem Mass Spectrometry 33%
• MCM4 33%
• MCM7 33%
• Biological Functions 33%
• Cell Cycle 33%
• Tandem Mass Spectrometry 33%
• Protein Family 33%
• DNA Synthesis 33%
• Carcinogenesis 33%
• Programmed Cell Death 33%
• Proteomics 33%